References

1. Christensen J, Grønborg TK, Sørensen MJ, Schendel D, Parner ET et al. (2013) Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309: 1696-1703 [CrossRef] [Google Scholar] [PubMed]
2. Neural Tube Defects: Condition Information (2017) National Institute of Child Health and Human Development. U.S. National Institutes of Health
3. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380: 2095-128 [CrossRef] [Google Scholar] [PubMed]
4. America's Children and the Environment
5. Samaco RC, Hogart A, LaSalle JM (2005) Epigenetic overlap in autismspectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet 14: 483-492 [CrossRef] [Google Scholar] [PubMed]
6. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, et al. (1989) Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262: 2847-2852 [CrossRef] [Google Scholar] [PubMed]
7. Copp AJ, Greene NDE (2010) Genetics and development of neural tube defects. J Pathol 220: 217-230 [CrossRef] [Google Scholar] [PubMed]
8. Holliday R (1990) DNA Methylation and Epigenetic Inheritance. Philos Trans R Soc Lond B Biol Sci 326: 329-338 [CrossRef] [Google Scholar] [PubMed]
9. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D et al. (2004) Dynamic mapping of human cortical development during childhood through early adulthood. Proceedings of the National Academy of Sciences of the United States of America 101: 8174-8179 [CrossRef] [Google Scholar] [PubMed]
10. Belmonte MK, Allen G, Beckel-Mitchener A, Boulanger LM, Carper RA, et al. (2004) Autism and abnormal development of brain connectivity. J Neurosci 24: 9228-9231 [CrossRef] [Google Scholar] [PubMed]
11. Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J, et al. (2013) The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry 84: 637-643 [CrossRef] [Google Scholar] [PubMed]
12. American Psychiatric Association (2000) Diagnosticand Statistical Manual of Mental Disorders. Text Revision. Washington, DC: American Psychiatric Association
13. Laegreid L, Kyllerman M, Hedner T, Hagberg B, Viggedahl G, et al. (1993) Benzodiazepine amplification of valproate teratogenic effects in children of mothers with absence epilepsy. Neuropediatrics 24: 88-92 [CrossRef] [Google Scholar] [PubMed]
14. Schneider T, Turczak J, Przewłocki R (2006) Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 31: 36-46 [CrossRef] [Google Scholar] [PubMed]
15. Roullet FI, Lai JK, Foster JA (2013) In Utero exposure to valproic acid and autism-a current review of clinical and animal studies. Neurotoxicol Teratol 36: 47-56 [CrossRef] [Google Scholar] [PubMed]
16. Wise J (2017) Women still not being told about pregnancy risks of valproate. Bmj [CrossRef] [Google Scholar] [PubMed]
17. Medicines and Healthcare products Regulatory Agency [View]
18. Kultima K, Nyström AM, Scholz B, Gustafson AL, Dencker L, et al. (2004) Valproic acid teratogenicity: A toxicogenomics approach. Environ Health Perspect 112: 1225-1235 [CrossRef] [Google Scholar] [PubMed]
19. Dencker L, Nau H, D'Argy R (1990) Marked accumulation of valproic acid in embryonic neuroepithelium of the mouse during early organogenesis. Teratology 41: 699-706 [CrossRef] [Google Scholar] [PubMed]
20. Bringas ME, Carvajal-Flores FN, López-Ramírez TA, Atzori M, Flores G, et al. (2013) Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder. Neuroscience 241: 170-187 [CrossRef] [Google Scholar] [PubMed]
21. Ingram JL, Peckham SM, Tisdale B, Rodier PM (2000) Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 22: 319-324 [CrossRef] [Google Scholar] [PubMed]
22. Lloyd KA (2013) A scientific review: mechanisms of valproate-mediated teratogenesis. Bioscience Horizons 6: hzt003-hzt003 [CrossRef] [Google Scholar]
23. Göttlicher M, Minucci S, Zhu P, Krämer OH, Schimpf A, Giavara S, et al. (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 20: 6969-6978 [CrossRef] [Google Scholar] [PubMed]
24. Go HS, Kim KC, Choi CS, Jeon SJ, Kwon KJ, et al. (2012) Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3beta/betacatenin pathway. Neuropharmacology 63: 1028-1041 [CrossRef] [Google Scholar] [PubMed]
25. Dai YC, Zhang HF, Schön M, Böckers TM, Han SP, et al. (2018). Neonatal Oxytocin Treatment Ameliorates Autistic-Like Behaviors and Oxytocin Deficiency in Valproic Acid-Induced Rat Model of Autism. Front Cell Neurosci 12: 355 [CrossRef] [Google Scholar] [PubMed]